Cancer stem cell hypothesis in thyroid cancer

Pathology International

Volumn 56, Issue 9, 2006, Pages 485-489

  Zhang, Ping ^a   Zuo, Hui ^a   Ozaki, Takashi ^a   Nakagomi, Nami ^a   Kakudo, Kennichi ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Cancer stem cell; Embryogenesis; Mixed medullary and follicular carcinoma; Stem cell; Thyroid

Indexed keywords

CANCER GROWTH; CANCER STEM CELL; CARCINOGENESIS; CELL DIFFERENTIATION; CELL MATURATION; CELL RENEWAL; CELL TRANSFORMATION; HUMAN; PRIORITY JOURNAL; REVIEW; SOLID TUMOR; TARGET CELL; THYROID CANCER; THYROID PAPILLARY CARCINOMA;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; MODELS, BIOLOGICAL; THYROID NEOPLASMS; TUMOR STEM CELLS;

EID: 33747457671     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2006.01995.x     Document Type: Review

References (43)

1. Sarlis NJ. Expression patterns of cellular growth-controlling genes in non-medullary thyroid cancer: Basic aspects. Rev Endocr Metab Disord 2000; 1: 183-96.
2. Kroll TG. Molecular events in follicular thyroid tumors. Cancer Treat Res 2004; 122: 85-105.
3. Asai N, Jijiwa M, Enomoto A et al. RET receptor signaling: Dysfunction in thyroid cancer and Hirschsprung's disease. Pathol Int 2006; 56: 164-72.
4. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer and cancer stem cells. Nature 2001; 414: 105-11.
5. Kakudo K, Miyauchi A, Katayama S, Watanabe K. Ultrastructural study of poorly differentiated medullary carcinoma of the thyroid. Virchows Arch A Pathol Anat Histopathol 1987; 410: 455-60.
6. Kakudo K, Carney JA, Sizemore GW. Medullary carcinoma of thyroid. Biologic behavior of the sporadic and familial neoplasm. Cancer 1985; 55: 2818-21.
7. Moniz S, Catarino AL, Marques AR, Cavaco B, Sobrinho L, Leite V. Clonal origin of non-medullary thyroid tumors assessed by non-random X-chromosome inactivation. Eur J Endocrinol 2002; 146: 27-33.
8. Williams ED. Thyroid tumorigenesis. Horm Res 1994; 42: 31-4.
9. Kim CFB, Jackson EL, Woolfenden AE et al. Identification of bronchoalveolar stem cells in normal lung and lung cancer. Cell 2005; 121: 823-35.
10. Park CH, Bergsagel DE, McCulloch EA. Mouse myeloma tumor stem cells: A primary cell culture assay. J Natl Cancer Inst 1971; 46: 411-22.
11. Meszoely IM, Means AL, Scoggins CR, Leach SD. Developmental aspects of early pancreatic cancer. Cancer J 2001; 7: 242-50.
12. Hudson DL. Epithelial stem cells in human prostate growth and disease. Prostate Cancer Prostatic Dis 2004; 7: 188-94.
13. Huntly BJ, Gilliland DG. Leukaemia stem cells and the evolution of cancer-stem-cell research. Nat Rev Cancer 2005; 5: 311-21.
14. Hope KJ, Jin L, Dick JE. Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity. Nat Immunol 2004; 5: 738-43.
15. Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 1997; 3: 730-37.
16. Carney DN. Lung cancer: Time to move on from chemotherapy. N Engl J Med 2002; 346: 126-8.
17. Nuciforo P, Fraggetta F. Cancer stem cell theory: Pathologists' considerations and ruminations about wasting time and wrong evaluations. J Clin Pathol 2004; 57: 782.
18. AI-Hajj M, Becker MW, Wicha M, Weissman I, Clarke MF. Therapeutic implications for cancer stem cells. Curr Opin Genet Dev 2004; 14: 43-7.
19. McDermott SP, Khwaja SS, Alexander CM. The transforming activity of Wnt effectors correlates with their ability to induce the accumulation of mammary progenitor cells. Proc Natl Acad Sci USA 2004; 101: 4158-63.
20. Jaiswal S, Traver D, Miyamato T, Akashi K, Lagasse E, Weissman IL. Expression of BCR/ABL and Bcl-2 in myeloid progenitors leads to myeloid leukemia. Proc Natl Acad Sci USA 2003; 100: 10 002-7.
21. Jamieson CH, Aille LE, Dylla SJ et al. Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. N Engl J Med 2004; 351: 657-67.
22. Porella G, Vitagliano D, Borselli C et al. Human N-ras, TRK-T1, and RET/PTC3 oncogenes, driven by a thyroglobulin promoter, differently affect the expression of differentiation markers and the proliferation of thyroid epithelial cells. Oncol Res 1999; 11: 421-7.
23. Jhiang SM, Sagartz JE, Tong Q et al. Targeted expression of the RET/PTC1 oncogene induces papillary thyroid carcinomas. Endocrinology 1996; 137: 375-8.
24. Trueba SS, Auge J, Mattei G et al. Pax8, TITF1, and FOXE1 gene expression patterns during human development: New insights into human thyroid development and thyroid dysgenesis-associated malformations. J Clin Endocrinol Metab 2005; 90: 455-62.
25. Rogers WM. Normal and anomalous development of the thyroid. In: Werner SC, Ingbar SH, eds. The Thyroid. New York: Harper & Row, 1971; 303-17.
26. Zelmanovitz F, Moraes IV, Spiro BL, Masiero PR. Activation of thyroid tissue in thyroglossal duct. Thyroid 2004; 14: 475-6.
27. Beckner ME, Shultz JJ, Richardson T. Solid and cystic ultimo-branchial body remnants in the thyroid. Arch Pathol Lab Med 1990; 114: 1049-52.
28. Preto A, Cameselle-Teijeiro J, Moldes-Boullosa J et al. Telomerase expression and proliferative activity suggest a stem cell role for thyroid solid cell nests. Mod Pathol 2004; 17: 819-26.
29. Burstein DE, Nagi C, Wang BY, Unger P. Immunohistochemical detection of p53 homolog p63 in solid cell nest, papillary thyroid carcinoma, and hashimoto's thyroiditis: A stem cell hypothesis of papillary carcinoma oncogenesis. Hum Pathol 2004; 35: 465-73.
30. Cameselle-Teijeiro J, Febles-Perez C, Sobrinbo-Simoes M. Papillary and mucoepidermoid carcinoma of the thyroid with anaplastic transformation: A case report with histologic and immunohistochemical findings that support a provocative histogenetic hypothesis. Pathol Res Pract 1995; 191: 1214-21.
31. Fernandes KJ, McKenzie IA, Mill P et al. A dermal niche for multipotent adult skin-derived precursor cells. Nat Cell Biol 2004; 6: 1082-93.
32. Tsonis PA. Regenerative biology: The emerging field of tissue repair and restoration. Differentiation 2002; 70: 397-409.
33. Shuji T, Norimasa K, Hajime S. Thyrocyte integration, and thyroid folliculogenesis and tissue regeneration: Perspective for thyroid tissue engineering. Pathol Int 2001; 51: 403-17.
34. Mori I, Nakamura M, Iteya I et al. Exogenous calcitonin suppresses growth fraction of thyroid C cells. Acta Histochem Cytochem 2003; 36: 439-42.
35. Kameda Y, Shigemoto H, Ikeda A. Development and cytodifferentiation of C cell complexes in dog fetal thyroids. An immunohistochemical study using anti-calcitonin, anti-C-thyroglobulin and anti-19S thyroglobulin antisera. Cell Tissue Res 1980; 206: 403-15.
36. Lagasse E, Shizuru JA, Uchida N, Tsukamoto A, Weissman IL. Toward regenerative medicine. Immunity 2001; 14: 425-36.
37. Butcher EC. Leukocyte-endothelial cell recognition: Three (or more) steps to specificity and diversity. Cell 1991; 67: 1033-6.
38. Galli R, Borello U, Gritti A et al. Skeletal myogenic potential of human and mouse neural stem cells. Nat Neurosci 2000; 3: 986-91.
39. Jiang Y, Jahagirdar BN, Reinhardt RL et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002; 418: 41-9.
40. Blau HM, Brazelton TR, Weimann JM. The evolving concept of a stem cell: Entity or function? Cell 2001; 105: 829-41.
41. Shen CN, Slack JM, Tosh D. Molecular basis of transdifferentiation of pancreas to liver. Nat Cell Biol 2000; 2: 879-87.
42. Ishigaki K, Namba H, Nakashima M et al. Aberrant localization of beta-catenin correlates with overexpression of its target gene in human papillary thyroid cancer. J Clin Endocrinol Metab 2002; 87: 3433-40.
43. Sell S. Stem cell origin of cancer and differentiation therapy. Crit Rev Oncol Hematol 2004; 51: 1-28.